Terms: = Prostate cancer AND NCOR2, SMRTE-tau, 9612, ENSG00000196498, SMRTE, TNRC14, TRAC-1, SMRT, CTG26, TRAC1
45 results:
1. Androgen receptor cofactors: A potential role in understanding prostate cancer.
Li X; Xiong H; Mou X; Huang C; Thomas ER; Yu W; Jiang Y; Chen Y
Biomed Pharmacother; 2024 Apr; 173():116338. PubMed ID: 38417290
[TBL] [Abstract] [Full Text] [Related]
2. Molecular complexity of intraductal carcinoma of the prostate.
Zhu S; Xu N; Zeng H
Cancer Med; 2024 Jan; 13(2):e6939. PubMed ID: 38379333
[TBL] [Abstract] [Full Text] [Related]
3. Early Plasma Circulating Tumor DNA as a Potential Biomarker of Disease Recurrence in Non-metastatic prostate cancer.
Fei X; Du X; Gong Y; Liu J; Fan L; Wang J; Wang Y; Zhu Y; Pan J; Dong B; Xue W
Cancer Res Treat; 2023 Jul; 55(3):969-977. PubMed ID: 36915250
[TBL] [Abstract] [Full Text] [Related]
4. Splice-disrupt genomic variants in prostate cancer.
Alanazi IO; Alamery SF; Ebrahimie E; Mohammadi-Dehcheshmeh M
Mol Biol Rep; 2022 Jun; 49(6):4237-4246. PubMed ID: 35286517
[TBL] [Abstract] [Full Text] [Related]
5. Reduced ncor2 expression accelerates androgen deprivation therapy failure in prostate cancer.
Long MD; Jacobi JJ; Singh PK; Llimos G; Wani SA; Rowsam AM; Rosario SR; Hoogstraat M; Linder S; Kirk J; Affronti HC; Bergman A; Zwart W; Campbell MJ; Smiraglia DJ
Cell Rep; 2021 Dec; 37(11):110109. PubMed ID: 34910907
[TBL] [Abstract] [Full Text] [Related]
6. Circulating tumour DNA reveals genetic traits of patients with intraductal carcinoma of the prostate.
Zhao J; Sun G; Zhu S; Dai J; Chen J; Zhang M; Ni Y; Zhang H; Shen P; Zhao X; Zhang B; Pan X; Nie L; Yin X; Liang J; Zhang X; Wang Z; Zhu X; Liao B; Liu Z; Armstrong CM; Gao AC; Huang H; Chen N; Zeng H
BJU Int; 2022 Mar; 129(3):345-355. PubMed ID: 34185954
[TBL] [Abstract] [Full Text] [Related]
7. DUB3 Promotes BET Inhibitor Resistance and cancer Progression by Deubiquitinating BRD4.
Jin X; Yan Y; Wang D; Ding D; Ma T; Ye Z; Jimenez R; Wang L; Wu H; Huang H
Mol Cell; 2018 Aug; 71(4):592-605.e4. PubMed ID: 30057199
[TBL] [Abstract] [Full Text] [Related]
8. The co-regulators SRC-1 and smrt are involved in interleukin-6-induced androgen receptor activation.
Wang Q; Wang H; Ju Q; Ding Z; Ge X; Shi QM; Zhou JL; Zhou XL; Zhang JP; Zhang MR; Yu HM; Xu LC
Eur Cytokine Netw; 2016 Nov; 27(4):108-113. PubMed ID: 28396297
[TBL] [Abstract] [Full Text] [Related]
9. Inhibition effect of cypermethrin mediated by co-regulators SRC-1 and smrt in interleukin-6-induced androgen receptor activation.
Wang Q; Zhou JL; Wang H; Ju Q; Ding Z; Zhou XL; Ge X; Shi QM; Pan C; Zhang JP; Zhang MR; Yu HM; Xu LC
Chemosphere; 2016 Sep; 158():24-9. PubMed ID: 27239967
[TBL] [Abstract] [Full Text] [Related]
10. Benign Prostatic Hyperplasia and the Risk of prostate cancer and Bladder cancer: A Meta-Analysis of Observational Studies.
Dai X; Fang X; Ma Y; Xianyu J
Medicine (Baltimore); 2016 May; 95(18):e3493. PubMed ID: 27149447
[TBL] [Abstract] [Full Text] [Related]
11. Identification of a novel fusion transcript between human relaxin-1 (RLN1) and human relaxin-2 (RLN2) in prostate cancer.
Tevz G; McGrath S; Demeter R; Magrini V; Jeet V; Rockstroh A; McPherson S; Lai J; Bartonicek N; An J; Batra J; Dinger ME; Lehman ML; Williams ED; Nelson CC
Mol Cell Endocrinol; 2016 Jan; 420():159-68. PubMed ID: 26499396
[TBL] [Abstract] [Full Text] [Related]
12. Bone stroma-derived cells change coregulators recruitment to androgen receptor and decrease cell proliferation in androgen-sensitive and castration-resistant prostate cancer cells.
Villagran MA; Gutierrez-Castro FA; Pantoja DF; Alarcon JC; Fariña MA; Amigo RF; Muñoz-Godoy NA; Pinilla MG; Peña EA; Gonzalez-Chavarria I; Toledo JR; Rivas CI; Vera JC; McNerney EM; Onate SA
Biochem Biophys Res Commun; 2015 Nov; 467(4):1039-45. PubMed ID: 26494300
[TBL] [Abstract] [Full Text] [Related]
13. Histone deacetylase 3 indirectly modulates tubulin acetylation.
Bacon T; Seiler C; Wolny M; Hughes R; Watson P; Schwabe J; Grigg R; Peckham M
Biochem J; 2015 Dec; 472(3):367-77. PubMed ID: 26450925
[TBL] [Abstract] [Full Text] [Related]
14. Mutation detection in formalin-fixed prostate cancer biopsies taken at the time of diagnosis using next-generation DNA sequencing.
Manson-Bahr D; Ball R; Gundem G; Sethia K; Mills R; Rochester M; Goody V; Anderson E; O'Meara S; Flather M; Keeling M; Yazbek-Hanna M; Hurst R; Curley H; Clark J; Brewer DS; McDermott U; Cooper C
J Clin Pathol; 2015 Mar; 68(3):212-7. PubMed ID: 25586381
[TBL] [Abstract] [Full Text] [Related]
15. Differential impact of tumor-infiltrating immune cells on basal and luminal cells: implications for tumor invasion and metastasis.
Song G; Hsiao H; Wang JL; Mannion C; Stojadinovic A; Avital I; Fu SW; Mason J; Chen W; Jewett A; Li H; Man YG
Anticancer Res; 2014 Nov; 34(11):6363-80. PubMed ID: 25368236
[TBL] [Abstract] [Full Text] [Related]
16. MEIS1 functions as a potential AR negative regulator.
Cui L; Li M; Feng F; Yang Y; Hang X; Cui J; Gao J
Exp Cell Res; 2014 Oct; 328(1):58-68. PubMed ID: 25158280
[TBL] [Abstract] [Full Text] [Related]
17. Different effect of sodium butyrate on cancer and normal prostate cells.
Paskova L; Smesny Trtkova K; Fialova B; Benedikova A; Langova K; Kolar Z
Toxicol In Vitro; 2013 Aug; 27(5):1489-95. PubMed ID: 23524101
[TBL] [Abstract] [Full Text] [Related]
18. Altered corepressor smrt expression and recruitment to target genes as a mechanism that change the response to androgens in prostate cancer progression.
Godoy AS; Sotomayor PC; Villagran M; Yacoub R; Montecinos VP; McNerney EM; Moser M; Foster BA; Onate SA
Biochem Biophys Res Commun; 2012 Jul; 423(3):564-70. PubMed ID: 22695118
[TBL] [Abstract] [Full Text] [Related]
19. Regulation of a novel androgen receptor target gene, the cyclin B1 gene, through androgen-dependent E2F family member switching.
Li Y; Zhang DY; Ren Q; Ye F; Zhao X; Daniels G; Wu X; Dynlacht B; Lee P
Mol Cell Biol; 2012 Jul; 32(13):2454-66. PubMed ID: 22508987
[TBL] [Abstract] [Full Text] [Related]
20. TNIP1, a retinoic acid receptor corepressor and A20-binding inhibitor of NF-κB, distributes to both nuclear and cytoplasmic locations.
Gurevich I; Zhang C; Francis N; Aneskievich BJ
J Histochem Cytochem; 2011 Dec; 59(12):1101-12. PubMed ID: 22147607
[TBL] [Abstract] [Full Text] [Related]
[Next]